Healthcare Analytical Testing Services Comprehensive Study by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, Microbial Testing), End User (Pharmaceutical, Medical Device Manufacturing) Players and Region - Global Market Outlook to 2030

Healthcare Analytical Testing Services Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Healthcare Analytical Testing Services Market Scope
Healthcare analytical testing services refers to material testing. Healthcare analytical services are used to confirms that the quality of products as well as purity product. Examine impurity which could infect the products during manufacturing or the early stages of product development. There are various types of healthcare analytical service testing such as method validation, environmental monitoring, bioanalytical services, raw Materials and microbial testing.

According to AMA, the Global Healthcare Analytical Testing Services market is expected to see growth rate of 20.3%

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Healthcare Analytical Testing Services market throughout the predicted period.

Eurofins Scientific (Luxembourg), Wuxi PharmaTech (China), Charles River Laboratories (United States), Almac Group (United Kingdom), PPD (United States), Intertek Group (United Kingdom), Source BioScience (United Kingdom), Anabiotec (Belgium), BioReliance (United States), Exova Group (United Kingdom) and Labcorp (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are SGS (Switzerland), Charles River (United States), Wuxi Pharmatech (China) and Pharmaceutical Product Development, LLC (PPD) (United States).

Segmentation Overview
The study have segmented the market of Global Healthcare Analytical Testing Services market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing) and Region with country level break-up.

On the basis of geography, the market of Healthcare Analytical Testing Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Up surging Demand of Outsourcing Analytical Testing and Growing Dependency on Fte Contracts in R&D Outsourcing

Market Growth Drivers:
Rising demand of analytical testing and Adoption of Analytical Testing of Biologics

Challenges:
Rising Need to Expand the Sensitivity of Analytical Methods

Restraints:
High Cost of Services and Lack of Skilled Professionals

Opportunities:
Adoption of Specialized Analytical Services and Increasing Demand of Healthcare Analytical Services in Emerging Economics

Market Leaders and their Expansionary Development Strategies
In January 2018, Almac Group has launched Bespoke Elemental Impurities Laboratory at their European Headquarters, Craigavon, United Kingdom.
In May 2018, Eurofins Scientific, key player in biopharmaceutical has signed agreement with Astellas Analytical Science Laboratories, Inc. for expansion of healthcare analytical testing services.


Key Target Audience
Healthcare Analytical Testing Service Providers, Pharmaceutical Firms, Healthcare Industries, Medical Expedient Manufacturing Industry, Government Agencies, Private Research Institutes, Government Research Institutes and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Method Validation
  • Environmental Monitoring
  • Bioanalytical Services
  • Stability
  • Raw Materials
  • Microbial Testing
By End User
  • Pharmaceutical
  • Medical Device Manufacturing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising demand of analytical testing
      • 3.2.2. Adoption of Analytical Testing of Biologics
    • 3.3. Market Challenges
      • 3.3.1. Rising Need to Expand the Sensitivity of Analytical Methods
    • 3.4. Market Trends
      • 3.4.1. Up surging Demand of Outsourcing Analytical Testing
      • 3.4.2. Growing Dependency on Fte Contracts in R&D Outsourcing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Analytical Testing Services, by Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Healthcare Analytical Testing Services (Value)
      • 5.2.1. Global Healthcare Analytical Testing Services by: Type (Value)
        • 5.2.1.1. Method Validation
        • 5.2.1.2. Environmental Monitoring
        • 5.2.1.3. Bioanalytical Services
        • 5.2.1.4. Stability
        • 5.2.1.5. Raw Materials
        • 5.2.1.6. Microbial Testing
      • 5.2.2. Global Healthcare Analytical Testing Services by: End User (Value)
        • 5.2.2.1. Pharmaceutical
        • 5.2.2.2. Medical Device Manufacturing
      • 5.2.3. Global Healthcare Analytical Testing Services Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Healthcare Analytical Testing Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eurofins Scientific (Luxembourg)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Wuxi PharmaTech (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Charles River Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Almac Group (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PPD (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Intertek Group (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Source BioScience (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Anabiotec (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BioReliance (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Exova Group (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Labcorp (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Healthcare Analytical Testing Services Sale, by Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Healthcare Analytical Testing Services (Value)
      • 7.2.1. Global Healthcare Analytical Testing Services by: Type (Value)
        • 7.2.1.1. Method Validation
        • 7.2.1.2. Environmental Monitoring
        • 7.2.1.3. Bioanalytical Services
        • 7.2.1.4. Stability
        • 7.2.1.5. Raw Materials
        • 7.2.1.6. Microbial Testing
      • 7.2.2. Global Healthcare Analytical Testing Services by: End User (Value)
        • 7.2.2.1. Pharmaceutical
        • 7.2.2.2. Medical Device Manufacturing
      • 7.2.3. Global Healthcare Analytical Testing Services Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Analytical Testing Services: by Type(USD Million)
  • Table 2. Healthcare Analytical Testing Services Method Validation , by Region USD Million (2018-2023)
  • Table 3. Healthcare Analytical Testing Services Environmental Monitoring , by Region USD Million (2018-2023)
  • Table 4. Healthcare Analytical Testing Services Bioanalytical Services , by Region USD Million (2018-2023)
  • Table 5. Healthcare Analytical Testing Services Stability , by Region USD Million (2018-2023)
  • Table 6. Healthcare Analytical Testing Services Raw Materials , by Region USD Million (2018-2023)
  • Table 7. Healthcare Analytical Testing Services Microbial Testing , by Region USD Million (2018-2023)
  • Table 8. Healthcare Analytical Testing Services: by End User(USD Million)
  • Table 9. Healthcare Analytical Testing Services Pharmaceutical , by Region USD Million (2018-2023)
  • Table 10. Healthcare Analytical Testing Services Medical Device Manufacturing , by Region USD Million (2018-2023)
  • Table 11. South America Healthcare Analytical Testing Services, by Country USD Million (2018-2023)
  • Table 12. South America Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 13. South America Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 14. Brazil Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 15. Brazil Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 16. Argentina Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 17. Argentina Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 18. Rest of South America Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 19. Rest of South America Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 20. Asia Pacific Healthcare Analytical Testing Services, by Country USD Million (2018-2023)
  • Table 21. Asia Pacific Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 22. Asia Pacific Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 23. China Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 24. China Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 25. Japan Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 26. Japan Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 27. India Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 28. India Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 29. South Korea Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 30. South Korea Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 31. Taiwan Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 32. Taiwan Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 33. Australia Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 34. Australia Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 37. Europe Healthcare Analytical Testing Services, by Country USD Million (2018-2023)
  • Table 38. Europe Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 39. Europe Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 40. Germany Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 41. Germany Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 42. France Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 43. France Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 44. Italy Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 45. Italy Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 46. United Kingdom Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 47. United Kingdom Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 48. Netherlands Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 49. Netherlands Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 50. Rest of Europe Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 51. Rest of Europe Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 52. MEA Healthcare Analytical Testing Services, by Country USD Million (2018-2023)
  • Table 53. MEA Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 54. MEA Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 55. Middle East Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 56. Middle East Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 57. Africa Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 58. Africa Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 59. North America Healthcare Analytical Testing Services, by Country USD Million (2018-2023)
  • Table 60. North America Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 61. North America Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 62. United States Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 63. United States Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 64. Canada Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 65. Canada Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 66. Mexico Healthcare Analytical Testing Services, by Type USD Million (2018-2023)
  • Table 67. Mexico Healthcare Analytical Testing Services, by End User USD Million (2018-2023)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Healthcare Analytical Testing Services: by Type(USD Million)
  • Table 80. Healthcare Analytical Testing Services Method Validation , by Region USD Million (2025-2030)
  • Table 81. Healthcare Analytical Testing Services Environmental Monitoring , by Region USD Million (2025-2030)
  • Table 82. Healthcare Analytical Testing Services Bioanalytical Services , by Region USD Million (2025-2030)
  • Table 83. Healthcare Analytical Testing Services Stability , by Region USD Million (2025-2030)
  • Table 84. Healthcare Analytical Testing Services Raw Materials , by Region USD Million (2025-2030)
  • Table 85. Healthcare Analytical Testing Services Microbial Testing , by Region USD Million (2025-2030)
  • Table 86. Healthcare Analytical Testing Services: by End User(USD Million)
  • Table 87. Healthcare Analytical Testing Services Pharmaceutical , by Region USD Million (2025-2030)
  • Table 88. Healthcare Analytical Testing Services Medical Device Manufacturing , by Region USD Million (2025-2030)
  • Table 89. South America Healthcare Analytical Testing Services, by Country USD Million (2025-2030)
  • Table 90. South America Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 91. South America Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 92. Brazil Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 93. Brazil Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 94. Argentina Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 95. Argentina Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 96. Rest of South America Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 97. Rest of South America Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 98. Asia Pacific Healthcare Analytical Testing Services, by Country USD Million (2025-2030)
  • Table 99. Asia Pacific Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 100. Asia Pacific Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 101. China Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 102. China Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 103. Japan Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 104. Japan Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 105. India Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 106. India Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 107. South Korea Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 108. South Korea Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 109. Taiwan Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 110. Taiwan Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 111. Australia Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 112. Australia Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 113. Rest of Asia-Pacific Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 114. Rest of Asia-Pacific Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 115. Europe Healthcare Analytical Testing Services, by Country USD Million (2025-2030)
  • Table 116. Europe Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 117. Europe Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 118. Germany Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 119. Germany Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 120. France Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 121. France Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 122. Italy Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 123. Italy Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 124. United Kingdom Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 125. United Kingdom Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 126. Netherlands Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 127. Netherlands Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 128. Rest of Europe Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 129. Rest of Europe Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 130. MEA Healthcare Analytical Testing Services, by Country USD Million (2025-2030)
  • Table 131. MEA Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 132. MEA Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 133. Middle East Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 134. Middle East Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 135. Africa Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 136. Africa Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 137. North America Healthcare Analytical Testing Services, by Country USD Million (2025-2030)
  • Table 138. North America Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 139. North America Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 140. United States Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 141. United States Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 142. Canada Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 143. Canada Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 144. Mexico Healthcare Analytical Testing Services, by Type USD Million (2025-2030)
  • Table 145. Mexico Healthcare Analytical Testing Services, by End User USD Million (2025-2030)
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Analytical Testing Services: by Type USD Million (2018-2023)
  • Figure 5. Global Healthcare Analytical Testing Services: by End User USD Million (2018-2023)
  • Figure 6. South America Healthcare Analytical Testing Services Share (%), by Country
  • Figure 7. Asia Pacific Healthcare Analytical Testing Services Share (%), by Country
  • Figure 8. Europe Healthcare Analytical Testing Services Share (%), by Country
  • Figure 9. MEA Healthcare Analytical Testing Services Share (%), by Country
  • Figure 10. North America Healthcare Analytical Testing Services Share (%), by Country
  • Figure 11. Global Healthcare Analytical Testing Services share by Players 2023 (%)
  • Figure 12. Global Healthcare Analytical Testing Services share by Players (Top 3) 2023(%)
  • Figure 13. Global Healthcare Analytical Testing Services share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 16. Eurofins Scientific (Luxembourg) Revenue: by Geography 2023
  • Figure 17. Wuxi PharmaTech (China) Revenue, Net Income and Gross profit
  • Figure 18. Wuxi PharmaTech (China) Revenue: by Geography 2023
  • Figure 19. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Charles River Laboratories (United States) Revenue: by Geography 2023
  • Figure 21. Almac Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Almac Group (United Kingdom) Revenue: by Geography 2023
  • Figure 23. PPD (United States) Revenue, Net Income and Gross profit
  • Figure 24. PPD (United States) Revenue: by Geography 2023
  • Figure 25. Intertek Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Intertek Group (United Kingdom) Revenue: by Geography 2023
  • Figure 27. Source BioScience (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Source BioScience (United Kingdom) Revenue: by Geography 2023
  • Figure 29. Anabiotec (Belgium) Revenue, Net Income and Gross profit
  • Figure 30. Anabiotec (Belgium) Revenue: by Geography 2023
  • Figure 31. BioReliance (United States) Revenue, Net Income and Gross profit
  • Figure 32. BioReliance (United States) Revenue: by Geography 2023
  • Figure 33. Exova Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Exova Group (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Labcorp (United States) Revenue, Net Income and Gross profit
  • Figure 36. Labcorp (United States) Revenue: by Geography 2023
  • Figure 37. Global Healthcare Analytical Testing Services: by Type USD Million (2025-2030)
  • Figure 38. Global Healthcare Analytical Testing Services: by End User USD Million (2025-2030)
  • Figure 39. South America Healthcare Analytical Testing Services Share (%), by Country
  • Figure 40. Asia Pacific Healthcare Analytical Testing Services Share (%), by Country
  • Figure 41. Europe Healthcare Analytical Testing Services Share (%), by Country
  • Figure 42. MEA Healthcare Analytical Testing Services Share (%), by Country
  • Figure 43. North America Healthcare Analytical Testing Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eurofins Scientific (Luxembourg)
  • Wuxi PharmaTech (China)
  • Charles River Laboratories (United States)
  • Almac Group (United Kingdom)
  • PPD (United States)
  • Intertek Group (United Kingdom)
  • Source BioScience (United Kingdom)
  • Anabiotec (Belgium)
  • BioReliance (United States)
  • Exova Group (United Kingdom)
  • Labcorp (United States)
Additional players considered in the study are as follows:
SGS (Switzerland) , Charles River (United States) , Wuxi Pharmatech (China) , Pharmaceutical Product Development, LLC (PPD) (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 208 Pages 90 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Healthcare Analytical Testing Services study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Healthcare Analytical Testing Services Market is gaining popularity and expected to see strong valuation by 2030 .
According to AMA, the Global Healthcare Analytical Testing Services market is expected to see growth rate of xx%.
The Healthcare Analytical Testing Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Healthcare Analytical Testing Services Market Report?